{
    "Trade/Device Name(s)": [
        "cobas 6000 Series System",
        "cobas c501 analyzer",
        "cobas e601 analyzer"
    ],
    "Submitter Information": "Roche Diagnostics",
    "510(k) Number": "K060373",
    "Predicate Device Reference 510(k) Number(s)": [
        "K953239",
        "K961481"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "CEM",
        "CGZ",
        "CZW",
        "DJG",
        "JFJ",
        "JGS",
        "KNK",
        "LDP",
        "JJE"
    ],
    "Summary Letter Date": "February 10, 2006",
    "Summary Letter Received Date": "February 13, 2006",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21CFR862.1600"
    ],
    "Regulation Name(s)": [
        "Potassium test system"
    ],
    "Analyte Class(es)": [
        "chemistry",
        "toxicology",
        "immunology"
    ],
    "Analyte(s)": [
        "Alpha-Amylase",
        "Uric Acid",
        "Complement C3c",
        "Sodium",
        "Potassium",
        "Chloride",
        "Acetaminophen",
        "Morphine and its metabolites"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Plasma",
        "Urine",
        "Cerebrospinal fluid",
        "Supernatant"
    ],
    "Specimen Container(s)": [
        "Plastic bottles with screw caps",
        "Plastic bottles with pierceable screw caps"
    ],
    "Instrument(s)/Platform(s)": [
        "cobas 6000 Series System",
        "cobas c501 analyzer",
        "cobas e601 analyzer"
    ],
    "Method(s)/Technology(ies)": [
        "Photometric assay",
        "Ion-selective electrode (ISE)",
        "Electrochemiluminescence (ECL) immunoassay",
        "Potentiometry"
    ],
    "Methodologies": [
        "Quantitative and qualitative in vitro analysis",
        "Endpoint",
        "Kinetic",
        "Electrochemiluminescence"
    ],
    "Submission Type(s)": [
        "Analyzer",
        "System",
        "Module",
        "Assay"
    ],
    "Document Summary": "FDA 510(k) summary for Roche cobas 6000 Series System, a modular automated chemistry and immunoassay analyzer for quantitative and qualitative determination of multiple analytes in body fluids.",
    "Indications for Use Summary": "The cobas 6000 series provides automated immunoassay and photometric analysis for in vitro qualitative and quantitative determination of a wide variety of analytes in body fluids, including specific assays for alpha-amylase, uric acid, complement C3c, sodium, potassium, chloride, acetaminophen, and opiates.",
    "fda_folder": "Clinical Chemistry"
}